Results 151 to 160 of about 8,161,910 (315)

Mortality in Transition: Study Protocol of the PrivMort Project, a multilevel convenience cohort study [PDF]

open access: gold, 2016
Darja Irdam   +15 more
openalex   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser   +14 more
wiley   +1 more source

Impact of the EU Carbon Border Adjustment Mechanism on the Global South

open access: yesDiscover Sustainability
The European Union Carbon Border Adjustment Mechanism (EU CBAM), currently in its transitional phase, represents a novel approach by the EU to address the threats of carbon leakage and environmental dumping, while promoting greener production systems and
Piergiuseppe Morone, Alessandra Alfino
doaj   +1 more source

Observation of asymmetric explosive density evolution in the deflagration-to-detonation transition for porous explosives [PDF]

open access: hybrid, 2021
Joseph W. Tringe   +9 more
openalex   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

open access: yesMolecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu   +18 more
wiley   +1 more source

Analysis of E3 Transitions in Ag-like High-Z Ions Observed with the NIST EBIT [PDF]

open access: gold, 2023
Endre Takács   +9 more
openalex   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

open access: yesMolecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak   +8 more
wiley   +1 more source

A transition-phase teleconnection of the Pacific quasi-decadal oscillation [PDF]

open access: hybrid, 2010
Shih‐Yu Wang   +3 more
openalex   +1 more source

Key transition technology of ski jumping based on inertial motion unit, kinematics and dynamics [PDF]

open access: gold, 2023
Jinglun Yu   +8 more
openalex   +1 more source

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

open access: yesMolecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy